Papillary Thyroid Carcinoma with Cervical Lymph Node (N1) Involvement at Intermediate Estimated Risk of Recurrence

This protocol applies to patients with papillary thyroid carcinoma (PTC) classified at intermediate estimated risk of recurrence, a designation driven by specific pathological or clinical features found at the time of surgical staging.

Defining the Clinical Scenario

Cervical lymph node (N1) involvement is a defining feature of this risk category and has direct implications for surgical planning and post-operative follow-up.

Treatment Approach

Surgical intervention is the cornerstone of management. The protocol specifies a thyroid resection strategy, with the extent of neck dissection determined by individual findings.

The complete protocol — including the full surgical algorithm, dissection criteria, and adjuvant considerations — is available through the link below.

Clinical Goals

Response to treatment is formally assessed at 6–18 months after primary therapy, using imaging, serum thyroglobulin, and anti-thyroglobulin antibody measurements. The aim is an excellent response across all these parameters.